Navigation Links
Concerns Regarding Overstenting Will Limit the US Market for Interventional Cardiology Devices Through 2022
Date:12/11/2013

TORONTO, Dec. 11, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States market for interventional cardiology (IC) devices will be hindered by ongoing concerns over overstenting and the appropriate use of percutaneous coronary intervention (PCI). As a result, PCI volumes will continue to decline through 2018 before stabilizing. However, total IC device revenues will continue to fall through 2022 due to cost sensitivity and healthcare reforms.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36799LOGO )

In this declining market, technological innovation will offer the best opportunity for companies to gain revenues. This has been most evident within the coronary stent segment. Abbott is expected to gain approval for the first bioresorbable vascular scaffold (BVS), ABSORB, in 2017; ABSORB received CE marking in Europe in 2011, and there is already significant interest in this device among US physicians. This product features a scaffold made of a polymer that completely dissolves in the vasculature over time, allowing the vessel to heal and return to normal. BVS are expected to offer clinical results similar to drug-eluting stents (DES), while supporting an improved safety profile. Although this product will initially be priced at a premium and will face significant competition from DES, ABSORB represents a major innovation and is likely to capture share within the coronary stent segment.

"A number of other stent technologies are expected to enter the market through 2022, many from smaller competitors focusing on niche segments," said MRG Senior Analyst Ian Swanson. "For example, Tryton Medical's TRYTON is a dedicated bifurcation stent, currently in clinical trials. Inspi
'/>"/>

SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
2. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
3. Obama administrations Plan B Decision Ignores Safety, Parental Rights Concerns
4. Green Valley Drugs Announces Voluntary Nationwide Recall Of All Lots Of All Sterile Products Compounded, Repackaged, And Distributed By Green Valley Drugs Due To Quality Control Concerns
5. Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen
6. DePuy Settlement News In Bellwether Case Concerns Plaintiffs Of The Hip Recall
7. New White Paper, "Five Biggest Myths about Medical Products Outsourcing," Finds OEMs Concerns are Often Unfounded
8. New Study Answers CMS/USPSTF Concerns for CT Colonography Screening Reimbursement: It is a Viable Option for the Medicare-Aged Population
9. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
10. Ambit Biosciences Provides Regulatory Update Following FDA Meeting Regarding Quizartinib (AC220)
11. Panacea Pharmaceuticals Presents Three Papers Regarding Its Nanoparticle-Based Therapeutic Cancer Vaccine at the Society for Immunotherapy of Cancer Annual Meeting at National Harbor, MD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 22, 2014  Sprout Pharmaceuticals today announced ... demonstrate that women treated with flibanserin up to 200 mg ... data were presented at the 20 th Annual Fall ... North America in Miami . ... response to the Complete Response Letter and the Formal Dispute ...
(Date:11/22/2014)... Statistics released from a number of organizations show that ... holidays, beginning with Thanksgiving eve, which is now termed ... data, highlighted in an Infographic released by ... annual Sober Days for the Holidays public awareness ... increased rates of DUI injuries and deaths during the ...
(Date:11/21/2014)... -- Alere Inc. (NYSE: ALR ), a global ... Cunningham as Vice President, Investor Relations. In this ... communications with the investment community. "As we ... increase shareholder value, it is critical that we effectively ... Executive Officer. "We are delighted that Juliet Cunningham ...
Breaking Medicine Technology:Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3Alarming Stats Show Holiday Drinking an Issue for Many 2Alere Appoints Juliet Cunningham to Lead Investor Relations 2
... SAN DIEGO, March 3, 2011 WHO:   , Awarepoint ... Cowen and Company 31st Annual Health Care Conference taking place ... Wednesday, March 9, 2011. Awarepoint is scheduled to present on ... Cowen and Company,s conferences are major industry events attracting ...
... part of its ongoing mission to serve cancer patients, ... launch of its enhanced website that provides cancer patients, ... spanning cancer prevention, education, patient care, advocacy, and financial ... a powerful new cancer resource navigator tool developed to ...
Cached Medicine Technology:Awarepoint Invited to Present at Cowen & Company 31st Annual Health Care Conference 2Awarepoint Invited to Present at Cowen & Company 31st Annual Health Care Conference 3Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients 2Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients 3
(Date:11/24/2014)... SweetDressy.com, a well-known dress supplier and leader in the ... Dresses. All these fresh items are offered at affordable ... special offer is valid until Dec. 20, 2014. Click ... working well in the fashion industry for years. They ... dresses may be the best products for many ladies ...
(Date:11/24/2014)... November 24, 2014 Mental health ... day. They break up families, ruin careers, and ... hope for those that suffer,” says Hardy ... is showing that our specialized nutritional treatments can ... appear on “Mind Over Matter”, the premiere episode ...
(Date:11/24/2014)... CO, and Philadelphia, PA (PRWEB) November 24, 2014 ... provider of care coordination and disease management services ... has chosen to implement Essette’s Medical Management software ... new Essette SaaS platform in a program to ... Essette suite includes Population Health Management, Care Management, ...
(Date:11/24/2014)... "My friend was killed when a vehicle struck ... in his motorized wheelchair," said an inventor from Southfield, ... with this idea so that people in wheelchairs would ... Safety Lites to make a wheelchair highly visible, especially ... that motorists can see the wheelchair. This helps reduce ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous ... promotion for many products, especially the beautiful colored wedding ... choice with amazing discounts, up to 90% off. Don’t ... is easy to buy colored wedding dresses in different ... also famous for delicate craftsmanship, elegant style and perfect ...
Breaking Medicine News(10 mins):Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2
... important one: The number of babies who die of SIDS, ... New Year,s Day. The suspected reason? Alcohol consumption by caretakers ... the University of California, San Diego, the study documenting the ... in the journal Addiction . The spike, write Phillips ...
... By Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Dec. 15 ... confirm a brain death diagnosis is not only unnecessary but may ... their loved one,s organs, a new study finds. Researchers reviewed ... adults and 82 children who had been declared brain dead. All ...
... HOUSTON - The recently identified TRIM24 protein plays an ... cell proliferation and, potentially, into breast cancer. Reporting ... by researchers at The University of Texas MD Anderson ... estrogen-responsive genes toward active expression. This expression, in turn, ...
... American Society for Radiation Oncology (ASTRO) has received a ... www.rtanswers.org . , The Web Health Awards is a ... 500 entries were submitted for the 2010 competition from ... were selected by a panel of national electronic health ...
... , WEDNESDAY, Dec. 15 (HealthDay News) -- People,s happiness ... study suggests. Researchers examined the link between economic ... of 10 years and an average of 22 years. ... poor, ex-Communist and capitalist. The findings challenge "recent ...
... at Virginia Commonwealth University Massey Cancer Center and the VCU ... gene therapy for renal cell carcinoma that has been shown ... site but also in distant tumors not directly infected by ... of kidney cancer in adults and currently there is no ...
Cached Medicine News:Health News:SIDS spikes on New Year's Day 2Health News:Second Brain Death Exam Unnecessary, Study Finds 2Health News:Second Brain Death Exam Unnecessary, Study Finds 3Health News:Protein disables p53, drives breast cells toward cancer transition 2Health News:Protein disables p53, drives breast cells toward cancer transition 3Health News:Novel therapy for metastatic kidney cancer developed at VCU Massey Cancer Center 2
For the quantitative determination of apolipoprotein B (apo B) in serum and plasma....
The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma....
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
Medicine Products: